LINDSEY GARNER: Open Payments
NPI 1255799730 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,996 in 112 payments from 24 companies in 2025. Trend: 2023 $2,747 · 2024 $4,950 · 2025 $2,996
Food & beverage: $2,996
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 19 | $337 |
| Alnylam Pharmaceuticals Inc. | 12 | $331 |
| HEARTFLOW, INC. | 3 | $278 |
| Abbott Laboratories | 3 | $273 |
| Philips North America LLC | 8 | $269 |
| Amgen Inc. | 16 | $223 |
| Medtronic, Inc. | 4 | $199 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $147 |
| Merck Sharp & Dohme LLC | 5 | $134 |
| Novo Nordisk Inc | 5 | $128 |
Products named: Kerendia, AMVUTTRA, FFRct, Ambulatory Monitoring & Diagnostics Undivided, REPATHA, AURORA EV-ICD MRI SURESCAN, MITRACLIP, LifeVest.
Industry payments across MS — which companies pay providers there.
